Meynert’s Nucleus Complex White Matter Abnormalities in Autism Spectrum Disorders: An MRI Study
DOI:
https://doi.org/10.6000/2292-2598.2016.04.04.1Keywords:
Autism, cholinergic system, Meynert’s nucleus, diffusion tensor imaging, white matterAbstract
Introduction: Cholinergic dysfunction has been proposed to play a role in autistic symtomatology. However, to date, its structural correlates are poorly understood.
Methods: Twenty-five low-functioning, non-verbal males with Autism Spectrum Disorders (ASD) and 25 controls were enrolled in the study. All underwent MR T1-weighted 3D Structural Imaging and Diffusion Tensor Imaging. Grey and white matter components of the Meynert’s Nucleus Complex were then identified on MR images, and both grey matter density and white matter mean Fractional Anisotropy in the Meynert’s Nucleus region of interest were quantified for each subject. Non-verbal IQ was assessed in all subjects with ASD.
Results: We showed reduced white matter Fractional Anisotropy in the bundles surrounding the Meynert’s Nucleus in ASD subjects compared to controls. Fractional Anisotropy in these bundles was positively associated with non-verbal IQ, independently from whole brain white matter mean Fractional Anisotropy. ASD subjects did not show significant abnormalities in Meynert’s Nucleus grey matter density.
Conclusions: Our findings suggest that white matter abnormalities in the Meynert’s Nucleus might be involved in the cholinergic deficits of ASD.
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association 2013. DOI: https://doi.org/10.1176/appi.books.9780890425596
Chez MG, Aimonovitch M, Buchanan T, Mrazek S, Tremb RJ. Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol 2004; 19: 165-9.
Karvat G, Kimchi T. Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism. Neuropsychopharmacology 2014; 39: 831-40.
https://doi.org/10.1038/npp.2013.274 DOI: https://doi.org/10.1038/npp.2013.274
Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R, et al. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 2002; 125: 1483-95.
https://doi.org/10.1093/brain/awf160 DOI: https://doi.org/10.1093/brain/awf160
Wang L, Almeida LE, Spornick NA, Kenyon N, Kamimura S, Khaibullina A, et al. Modulation of social deficits and repetitive behaviors in a mouse model of autism: The role of the nicotinic cholinergic system. Psychopharmacology 2015; 232: 4303-16.
https://doi.org/10.1007/s00213-015-4058-z DOI: https://doi.org/10.1007/s00213-015-4058-z
Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, et al. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 2001; 158: 1058-66.
https://doi.org/10.1176/appi.ajp.158.7.1058 DOI: https://doi.org/10.1176/appi.ajp.158.7.1058
Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Tsujii M, Futatsubashi M, et al. Reduced acetylcholinesterase activity in the fusiform gyrus in adults with autism spectrum disorders. Arch Gen Psychiatry 2011; 68: 306-13.
https://doi.org/10.1001/archgenpsychiatry.2011.4 DOI: https://doi.org/10.1001/archgenpsychiatry.2011.4
Wang L, Almeida LE, Nettleton M, et al. Altered nocifensive behavior in animal models of autism spectrum disorder: The role of the nicotinic cholinergic system. Neuropharmacology 2016; 111: 323-334.
https://doi.org/10.1016/j.neuropharm.2016.09.013 DOI: https://doi.org/10.1016/j.neuropharm.2016.09.013
McGaughy J, Everitt BJ, Robbins TW, Sarter M. The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behav Brain Res 2000; 115: 251-63.
https://doi.org/10.1016/S0166-4328(00)00262-X DOI: https://doi.org/10.1016/S0166-4328(00)00262-X
Luongo FJ, Horn ME, Sohal VS. Putative microcircuit-level substrates for attention are disrupted in mouse models of autism. Biol Psychiatry 2016; 79: 667-75.
https://doi.org/10.1016/j.biopsych.2015.04.014 DOI: https://doi.org/10.1016/j.biopsych.2015.04.014
Van Schalkwyk GI, Lewis AS, Qayyum Z, Koslosky K, Picciotto MR, Volkmar FR. Reduction of aggressive episodes after repeated transdermal nicotine administration in a hospitalized adolescent with Autism Spectrum Disorder. J Autism Dev Disord 2015; 45: 3061-6. DOI: https://doi.org/10.1007/s10803-015-2471-0
Mesulam MM, Mufson EJ, Levey AI, Wainer BH. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical coa, diagonal band nuclei, connections of the septal areleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 1983; 214(2): 170-97.
https://doi.org/10.1002/cne.902140206 DOI: https://doi.org/10.1002/cne.902140206
Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000; 30: 205-23.
https://doi.org/10.1023/A:1005592401947 DOI: https://doi.org/10.1023/A:1005592401947
Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24: 659-85.
https://doi.org/10.1007/BF02172145 DOI: https://doi.org/10.1007/BF02172145
Leiter RG. Instruction Manual for the Leiter International Performance Scale. Wood Dale, Il: Stoelting Co 1979.
Zaborszky L, Hoemke L, Mohlberg H, Schleicher A, Amunts K, Zilles K. Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain. NeuroImage 2008; 42: 1127-41.
https://doi.org/10.1016/j.neuroimage.2008.05.055 DOI: https://doi.org/10.1016/j.neuroimage.2008.05.055
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004; 23 Suppl 1: S208-19.
https://doi.org/10.1016/j.neuroimage.2004.07.051 DOI: https://doi.org/10.1016/j.neuroimage.2004.07.051
Pardini M, Garaci FG, Bonzano L, Roccatagliata L, Palmieri MG, Pompili E, et al. White matter reduced streamline coherence in young men with autism and mental retardation. Eur J Neurol 2009; 16: 1185-90.
https://doi.org/10.1111/j.1468-1331.2009.02699.x DOI: https://doi.org/10.1111/j.1468-1331.2009.02699.x
Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 2006; 31: 1487-505.
https://doi.org/10.1016/j.neuroimage.2006.02.024 DOI: https://doi.org/10.1016/j.neuroimage.2006.02.024
Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001; 20: 45-57.
https://doi.org/10.1109/42.906424 DOI: https://doi.org/10.1109/42.906424
van Dalen JW, Caan MW, van Gool WA, Richard E. Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert. Brain Imaging Behav 2016; Oct 27. [Epub ahead of print]. DOI: https://doi.org/10.1007/s11682-016-9631-5
Pardini M, Elia M, Garaci FG, Guida S, Coniglione F, Krueger F, et al. Long-term cognitive and behavioral therapies, combined with augmentative communication, are related to uncinate fasciculus integrity in autism. J Autism Dev Disord 2012; 42: 585-92.
https://doi.org/10.1007/s10803-011-1281-2 DOI: https://doi.org/10.1007/s10803-011-1281-2
Deutsch SI, Burket JA, Urbano MR, Benson AD. The α7 nicotinic acetylcholine receptor: A mediator of pathogenesis and therapeutic target in autism spectrum disorders and Down syndrome. Biochem Pharmacol 2015; 97: 363-77.
https://doi.org/10.1016/j.bcp.2015.06.005 DOI: https://doi.org/10.1016/j.bcp.2015.06.005
Bocti C, Swartz RH, Gao FQ, Sahlas DJ, Behl P, Black SE, et al. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia. Stroke 2005; 36: 2126-31.
https://doi.org/10.1161/01.STR.0000183615.07936.b6 DOI: https://doi.org/10.1161/01.STR.0000183615.07936.b6
Oginsky MF, Cui N, Zhong W, Johnson CM, Jiang C. Alterations in the cholinergic system of brain stem neurons in a mouse model of Rett syndrome. Am J Physiol Cell Physiol 2014; 307(6): C508-C520. DOI: https://doi.org/10.1152/ajpcell.00035.2014
Freeman SM, Inoue K, Smith AL, Goodman MM, Young LJ. The neuroanatomical distribution of oxytocin receptor binding and mRNA in the male rhesus macaque (Macaca mulatta). Psychoneuroendocrinology 2014; 45: 128-41.
https://doi.org/10.1016/j.psyneuen.2014.03.023 DOI: https://doi.org/10.1016/j.psyneuen.2014.03.023
Emberti Gialloreti L, Benvenuto A, Benassi F, Curatolo P. Are caesarean sections, induced labor and oxytocin regulation linked to Autism Spectrum Disorders? Med Hypotheses 2014; 82: 713-8.
https://doi.org/10.1016/j.mehy.2014.03.011 DOI: https://doi.org/10.1016/j.mehy.2014.03.011
Kilimann I, Grothe M, Heinsen H, et al. Subregional basal forebrain atrophy in Alzheimer’s disease: a multicentre study. J Alzheimers Dis 2014; 40: 687-700. DOI: https://doi.org/10.3233/JAD-132345
Kim HJ, Lee JE, Shin SJ, Sohn YH, Lee PH. Analysis of the substantia innominata volume in patients with Parkinson’s disease with dementia, dementia with Lewy bodies, and Alzheimer’s disease. J Mov Disord 2011; 4: 68-72.
https://doi.org/10.14802/jmd.11014 DOI: https://doi.org/10.14802/jmd.11014
Gratwicke J, Kahan J, Zrinzo L, et al. The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia? Neurosci Biobehav Rev 2013; 37: 2676-88.
https://doi.org/10.1016/j.neubiorev.2013.09.003 DOI: https://doi.org/10.1016/j.neubiorev.2013.09.003
Kuhn J, Hardenacke K, Lenartz D, et al. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia. Mol Psychiatry 2014; 20(3): 353-60.
https://doi.org/10.1038/mp.2014.32 DOI: https://doi.org/10.1038/mp.2014.32